Literature DB >> 32871016

Improving the Stability of Maleimide-Thiol Conjugation for Drug Targeting.

Marianne Lahnsteiner1, Alexander Kastner1, Josef Mayr1, Alexander Roller1, Bernhard K Keppler1,2, Christian R Kowol1,2.   

Abstract

Maleimides are essential compounds for drug conjugation reactions via thiols to antibodies, peptides and other targeting units. However, one main drawback is the occurrence of thiol exchange reactions with, for example, glutathione resulting in loss of the targeting ability. A new strategy to overcome such retro-Michael exchange processes of maleimide-thiol conjugates by stabilization of the thiosuccinimide via a transcyclization reaction is presented. This reaction enables the straightforward synthesis of stable maleimide-thiol adducts essential in drug-conjugation applications.
© 2020 The Authors. Published by Wiley-VCH GmbH.

Entities:  

Keywords:  bioconjugation; bioorganic chemistry; drug delivery; maleimide; retro-Michael reactions

Mesh:

Substances:

Year:  2020        PMID: 32871016      PMCID: PMC7756610          DOI: 10.1002/chem.202003951

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  21 in total

1.  Rapid, stable, chemoselective labeling of thiols with Julia-Kocieński-like reagents: a serum-stable alternative to maleimide-based protein conjugation.

Authors:  Narihiro Toda; Shigehiro Asano; Carlos F Barbas
Journal:  Angew Chem Int Ed Engl       Date:  2013-10-02       Impact factor: 15.336

2.  Rational Design of an Ultrasensitive and Highly Selective Chemodosimeter by a Dual Quenching Mechanism for Cysteine Based on a Facile Michael-Transcyclization Cascade Reaction.

Authors:  Xiangmin Li; Yongjun Zheng; Hongjuan Tong; Rui Qian; Lin Zhou; Guixia Liu; Yun Tang; Hao Li; Kaiyan Lou; Wei Wang
Journal:  Chemistry       Date:  2016-05-31       Impact factor: 5.236

3.  Enzymatic Cleavage and Subsequent Facile Intramolecular Transcyclization for in Situ Fluorescence Detection of γ-Glutamyltranspetidase Activities.

Authors:  Hongjuan Tong; Yongjun Zheng; Li Zhou; Xiangmin Li; Rui Qian; Rui Wang; Jianhong Zhao; Kaiyan Lou; Wei Wang
Journal:  Anal Chem       Date:  2016-11-03       Impact factor: 6.986

4.  Stabilization of cysteine-linked antibody drug conjugates with N-aryl maleimides.

Authors:  R James Christie; Ryan Fleming; Binyam Bezabeh; Rob Woods; Shenlan Mao; Jay Harper; Augustine Joseph; Qianli Wang; Ze-Qi Xu; Herren Wu; Changshou Gao; Nazzareno Dimasi
Journal:  J Control Release       Date:  2015-09-24       Impact factor: 9.776

5.  Long-term stabilization of maleimide-thiol conjugates.

Authors:  Shaun D Fontaine; Ralph Reid; Louise Robinson; Gary W Ashley; Daniel V Santi
Journal:  Bioconjug Chem       Date:  2014-12-26       Impact factor: 4.774

Review 6.  Brentuximab vedotin.

Authors:  Changchun Deng; Beiqing Pan; Owen A O'Connor
Journal:  Clin Cancer Res       Date:  2012-11-15       Impact factor: 12.531

7.  Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy.

Authors:  Xiang Lan Wu; Jong Ho Kim; Heebeom Koo; Sang Mun Bae; Hyeri Shin; Min Sang Kim; Byung-Heon Lee; Rang-Woon Park; In-San Kim; Kuiwon Choi; Ick Chan Kwon; Kwangmeyung Kim; Doo Sung Lee
Journal:  Bioconjug Chem       Date:  2010-02-17       Impact factor: 4.774

8.  Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates.

Authors:  Robert P Lyon; Jocelyn R Setter; Tim D Bovee; Svetlana O Doronina; Joshua H Hunter; Martha E Anderson; Cindy L Balasubramanian; Steven M Duniho; Chris I Leiske; Fu Li; Peter D Senter
Journal:  Nat Biotechnol       Date:  2014-09-07       Impact factor: 54.908

9.  EGFR-targeting peptide-coupled platinum(IV) complexes.

Authors:  Josef Mayr; Sonja Hager; Bettina Koblmüller; Matthias H M Klose; Katharina Holste; Britta Fischer; Karla Pelivan; Walter Berger; Petra Heffeter; Christian R Kowol; Bernhard K Keppler
Journal:  J Biol Inorg Chem       Date:  2017-04-12       Impact factor: 3.358

10.  Improved Stability and Tunable Functionalization of Parallel β-Sheets via Multicomponent N-Alkylation of the Turn Moiety.

Authors:  Manuel G Ricardo; Celia G Moya; Carlos S Pérez; Andrea Porzel; Ludger A Wessjohann; Daniel G Rivera
Journal:  Angew Chem Int Ed Engl       Date:  2019-12-04       Impact factor: 15.336

View more
  6 in total

1.  Chromone Derivatives CM3a Potently Eradicate Staphylococcus aureus Biofilms by Inhibiting Cell Adherence.

Authors:  Qing Zhan; Yanlei Xu; Lingling Zhan; Bingjie Wang; Yinjuan Guo; Xiaocui Wu; Wenxiu Ai; Zengqiang Song; Fangyou Yu
Journal:  Infect Drug Resist       Date:  2021-03-11       Impact factor: 4.003

Review 2.  Linkers: An Assurance for Controlled Delivery of Antibody-Drug Conjugate.

Authors:  Rotimi Sheyi; Beatriz G de la Torre; Fernando Albericio
Journal:  Pharmaceutics       Date:  2022-02-11       Impact factor: 6.321

3.  Evidence of Isomerization in the Michael-Type Thiol-Maleimide Addition: Click Reaction between L-Cysteine and 6-Maleimidehexanoic Acid.

Authors:  Víctor Alfonso Niño-Ramírez; Diego Sebastián Insuasty-Cepeda; Zuly Jenny Rivera-Monroy; Mauricio Maldonado
Journal:  Molecules       Date:  2022-08-09       Impact factor: 4.927

4.  Context-Dependence of the Reactivity of Cysteine and Lysine Residues.

Authors:  Linus B Boll; Ronald T Raines
Journal:  Chembiochem       Date:  2022-06-01       Impact factor: 3.461

5.  Improving the Stability of Maleimide-Thiol Conjugation for Drug Targeting.

Authors:  Marianne Lahnsteiner; Alexander Kastner; Josef Mayr; Alexander Roller; Bernhard K Keppler; Christian R Kowol
Journal:  Chemistry       Date:  2020-10-27       Impact factor: 5.236

6.  Stability of Maleimide-PEG and Mono-Sulfone-PEG Conjugation to a Novel Engineered Cysteine in the Human Hemoglobin Alpha Subunit.

Authors:  Chris E Cooper; Matthew Bird; XiaoBo Sheng; Ji-Won Choi; Gary G A Silkstone; Michelle Simons; Natalie Syrett; Riccardo Piano; Luca Ronda; Stefano Bettati; Gianluca Paredi; Andrea Mozzarelli; Brandon J Reeder
Journal:  Front Chem       Date:  2021-07-26       Impact factor: 5.221

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.